“…Pre-clinical studies have demonstrated peripheral nerve injury-induced neuroimmune activation in brain regions responsible for the modulation of nociception and/or affect, including the prefrontal cortex (Apkarian et al, 2006, Al-Amin et al, 2011. Furthermore, the expression of genes coding for the pro-inflammatory cytokines IL-1β, IL-6 and/or TNFα, is enhanced in brain regions responsible for processing emotion and pain in animal models of depression with concomitant inflammatory (Kim et al, 2012, Arora et al, 2011 and neuropathic (Norman et al, 2010, Apkarian et al, 2006, Burke et al, 2013a, Burke et al, 2013b pain-related responding. Thus, modulating neuroimmune responses has been proposed as a novel target for the treatment of CNS disorders with an inflammatory component, including depression and associated chronic pain.…”